Scott A Hammond

Scott A Hammond

UNVERIFIED PROFILE

Are you Scott A Hammond?   Register this Author

Register author
Scott A Hammond

Scott A Hammond

Publications by authors named "Scott A Hammond"

Are you Scott A Hammond?   Register this Author

28Publications

1092Reads

46Profile Views

Combination therapy with an OX40L fusion protein and a vaccine targeting the transcription factor twist inhibits metastasis in a murine model of breast cancer.

Oncotarget 2017 Oct 5;8(53):90825-90841. Epub 2017 Aug 5.

Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.19967DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710887PMC
October 2017

Enhanced immunotherapy by combining a vaccine with a novel murine GITR ligand fusion protein.

Oncotarget 2017 Sep 7;8(43):73469-73482. Epub 2017 Sep 7.

Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.20703DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650275PMC
September 2017

Oncolytic VSV Primes Differential Responses to Immuno-oncology Therapy.

Mol Ther 2017 08 2;25(8):1917-1932. Epub 2017 Jun 2.

MedImmune, LLC, One Medimmune Way, Gaithersburg, MD 20878, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymthe.2017.05.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542805PMC
August 2017

CEA/CD3-bispecific T cell-engaging (BiTE) antibody-mediated T lymphocyte cytotoxicity maximized by inhibition of both PD1 and PD-L1.

Cancer Immunol Immunother 2015 Jun 6;64(6):677-88. Epub 2015 Mar 6.

Section of Applied Therapeutics, Department of Surgery, Duke University Medical Center, 403 MSRB, Research Drive, Durham, NC, 27710, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-015-1671-yDOI Listing
June 2015

The immune microenvironment: a major player in human cancers.

Int Arch Allergy Immunol 2014 13;164(1):13-26. Epub 2014 May 13.

Cancer, Immune Control and Escape, UMRS1138, Cordeliers Research Center, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000362332DOI Listing
August 2014

Tertiary lymphoid structures in human lung cancers, a new driver of antitumor immune responses.

Oncoimmunology 2014 29;3:e28976. Epub 2014 May 29.

The Laboratory of Cancer and Immune escape; INSERM U1138; Cordeliers Research Center; Paris, France ; University Pierre and Marie Curie; UMRS1138; Paris, France ; University Paris Descartes; UMRS1138; Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.28976DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106161PMC
May 2014

Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells.

Cancer Res 2014 Feb 23;74(3):705-15. Epub 2013 Dec 23.

Authors' Affiliations: Laboratory Immune Microenvironment and Tumors, INSERM U872, Cordeliers Research Center; University Pierre et Marie Curie; University Paris Descartes, UMRS 872; Departments of Pathology and Thoracic Surgery, Hôtel Dieu Hospital, AP-HP; Department of Pathology, Institut Mutualiste Montsouris; Department of Immunology, European Georges Pompidou Hospital, AP-HP, Paris, France; and Oncology Research, MedImmune LLC, Gaithersburg, Maryland.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-13-1342DOI Listing
February 2014

Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells.

J Clin Invest 2004 Apr;113(7):998-1007

Molecular Immunogenetics and Vaccine Research Section, Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1578, USA.

View Article

Download full-text PDF

Source
http://www.jci.org/articles/view/20261
Publisher Site
http://dx.doi.org/10.1172/JCI20261DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC379323PMC
April 2004

Transcutaneous immunization and immunostimulant strategies.

Immunol Allergy Clin North Am 2003 Nov;23(4):787-813

IOMAI Corporation, 20 Firstfield Road, Suite 250, Gaithersburg, MD 20878, USA.

View Article

Download full-text PDF

Source
November 2003